Quantum Academy is now open. Enroll in live online training – see the schedule.
Skip to content
Browse courses

Quantum-Safe Pharma Intensive

A full-day workshop for pharma and biotech teams planning a PQC migration through change control. Leave with an inventory plan and year-one roadmap.

8 hours Up to 7.5 CPE credits Practitioner Pharma & Life Sciences Live Online / In-Person US$1,499–1,999

Pharmaceutical and biotech companies modify validated systems only through change control, with documented testing and evidence an inspector can review. In a post-quantum cryptography (PQC) migration, replacing an algorithm, a cryptographic library, or a certificate authority in a GxP system is one of those changes. Regulators, industry bodies, and trading partners also set the cryptography of some interfaces, so part of the migration depends on their timelines. In this workshop, you build the program plan for that migration, with each change to a validated system planned through change control.

Signed GxP records have to stay trustworthy for their whole retention period. An EU clinical trial master file has to be retained for at least 25 years after the trial ends. NIST’s draft transition guidance proposes disallowing every quantum-vulnerable public-key algorithm after 2035, as The Two Dates in NIST IR 8547 That Govern Your Migration Plan explains. The Signature Supply Chain: How Deep Does Digital Trust Go? notes that signatures on batch release records must stay verifiable for inspection through the product’s shelf life and beyond.

We run this intensive as an eight-hour planning workshop, in one day in person or in two four-hour sessions live online. You work from your own GxP system list, supplier agreements, and retention schedules, or from a sample pharmaceutical company we provide. No cryptography background is needed. You leave with a draft program plan and a year-one roadmap that quality assurance can review, with the assumptions you still need to check written down.

Who this intensive is for

Program managers and PMO leads attend with the CISO or CIO who will sponsor the migration. The intensive is also for IT quality and computerized system validation leads, manufacturing and laboratory systems owners, serialization and supply chain leads, regulatory operations, and security architects. Procurement, supplier quality, and compliance belong in the room too. We recommend sending a mixed group from one company, ideally the people who would be members of its quantum readiness steering committee. The person who owns the validation master plan rarely owns the TLS configuration or the trading-partner credentials.

Bring at least one person from quality assurance. Many of the sequencing decisions in this workshop are change control decisions.

The intensive is for pharmaceutical and biotech companies, including those that manufacture through contract development and manufacturing organizations (CDMOs). If you run a health system or build medical devices, the Quantum-Safe Healthcare Intensive covers your estate. To work through confidential detail with only your own colleagues present, book the intensive as private team training through training@quantumacademy.com.

What you’ll be able to do afterward

  • Make the case that a pharma PQC migration is a multi-year program, and map who controls each part of your estate
  • Draft a program charter and business case, and define a steering committee that includes quality assurance
  • Plan a cryptographic inventory in risk order, starting from your GxP system list and validation records
  • Score and tier your estate without guessing unknowns, and plan how one archive’s signatures stay verifiable within ALCOA+ expectations
  • Classify suppliers and CDMOs by their effect on your timeline, and write clauses for contracts and quality agreements
  • Map the cryptography you cannot change yourself, from FDA and EMA submission gateways to DSCSA trading-partner credentials
  • Classify cryptographic changes by GxP risk, and structure the program into workstreams and a year-one plan with board KPIs

What you leave with

Every participant receives the course handbook, a PDF of every slide with notes that explain it in full. Each participant also receives a PDF copy of Quantum Ready, the companion book to the framework the day draws on. During the day, you build first versions of these working documents:

  • An estate map that marks what your teams, suppliers, CDMOs, regulators, and trading partners control
  • A program charter and a steering committee structure that includes quality assurance
  • An inventory plan, with its tracks, starting records, and order
  • An initial priority list with evidence gaps recorded, and a signature longevity plan for one regulated archive
  • A supplier and CDMO register with graded dates, and draft contract and quality agreement clauses
  • A register of the requirements and dates that regulators and trading partners set
  • A classification matrix for cryptographic changes, and a workstream structure with role and resource assumptions
  • A year-one plan by quarter, with board KPIs and the decisions you need from others

The working documents are editable and yours to keep.

Preparing for the day

You can work through the day with data from your own company or with a sample pharmaceutical company we provide. If you bring approximate figures from your own estate, you apply each module directly to your systems, and the documents you leave with contain your own numbers. If you cannot share your data or have not had time to collect it, you work with the sample company’s illustrative figures. You then apply the same templates to your own estate when you return to work.

Your joining instructions, sent seven days before the course, list what to gather if you want to use your own data. Approximate figures are enough:

  • Your GxP system inventory, with the supplier of each system
  • The records an inventory would start from, such as validation records and the equipment register
  • Your supplier and CDMO list, with contract and quality agreement renewal dates
  • Retention periods for your main regulated archives, such as trial master files and batch records
  • Your submission gateways, trading-partner connections, and any deadlines your organization already tracks

You decide what you share with the room. If you cannot take validation records out of your document system, bring a simplified list instead.

The day

The day draws on the lifecycle of the Applied Quantum PQC Migration Framework and, for manufacturing and laboratory systems, on its OT & Critical Infrastructure Extension. The instructor starts each module with a short briefing. You then apply the module’s template to your own estate or to the sample pharmaceutical company.

In person, we teach the intensive from 09:00 to 17:00 local time, with lunch and two breaks:

  • 09:00–09:50Module 1. The shape of a pharma migration
  • 09:50–10:40Module 2. Mandate, governance, and the business case
  • 10:40–11:00Break
  • 11:00–11:45Module 3. Inventory planning across the GxP estate
  • 11:45–12:30Module 4. Risk scoring and signed records
  • 12:30–13:30Lunch
  • 13:30–14:20Module 5. Suppliers, CDMOs, and quality agreements
  • 14:20–15:10Module 6. Regulators and trading partners
  • 15:10–15:30Break
  • 15:30–16:15Module 7. Change control and program structure
  • 16:15–17:00Module 8. Year-one plan, KPIs, and the asks

Live online, we teach it in two four-hour sessions on consecutive days, each with a short break. We cover Modules 1 to 4 in the first session and Modules 5 to 8 in the second.

Module 1 The shape of a pharma migration

The instructor walks through the domains of a pharmaceutical estate, from research and clinical systems to manufacturing, laboratories, quality records, and the supply chain. You then map your own estate, marking the validated systems and whether your teams, a supplier, a CDMO, a regulator, or a trading partner controls each part.

Module 2 Mandate, governance, and the business case

You draft a charter with two outcomes: meeting your dated obligations, and being able to change cryptography on a planned date. In GxP terms, you change an algorithm once, in qualified infrastructure, then regression-test what depends on it. You define a steering committee that includes quality assurance and validation, and build the business case with planned system upgrades shown separately from new money.

Module 3 Inventory planning across the GxP estate

You plan the inventory in tracks for validated applications, manufacturing and laboratory equipment, signed archives, external interfaces, and shared IT and PKI. You start each track from a record you already hold and prioritize externally connected systems whose data or signing keys must stay protected for years. For equipment, you open a cryptographic ownership register naming, for each credential or signing key, who can change it and who approves.

Module 4 Risk scoring and signed records

You score the estate on data exposure, trust-infrastructure criticality, migration feasibility, and regulatory pressure, and record unknowns instead of guessing them. You then tier each fully scored entry and give every blocked high-priority entry an owner and an interim treatment. For one regulated archive, you draft a signature longevity plan: how long its signatures must stay verifiable, and how to re-sign or re-timestamp it without altering originals.

Module 5 Suppliers, CDMOs, and quality agreements

You classify suppliers, equipment makers, and CDMOs by how much of your timeline they control, and open every conversation with the same two questions about crypto-agility. You grade every date they give you as committed, forecast, announced, or unknown. You draft clauses for contracts and quality agreements, from cryptographic disclosure to subcontractor flow-down, as in Third-Party Cryptographic Risk at Enterprise Scale. You add matching entries to user requirements specifications, so validation testing includes a rehearsed algorithm change.

Module 6 Regulators and trading partners

You record each interface whose cryptography others set as its own dependency, from FDA and EMA submission gateways to DSCSA trading-partner credentials and serialization data exchanges. For trading partners you cannot compel, you plan a short readiness inquiry and test windows before any cutover. You classify each regulatory development as confirmed, proposed, or signaled, and plan against the EU, NIST, and UK NCSC milestones in Where Every Country Stands on Post-Quantum Migration.

Module 7 Change control and program structure

You draft a classification matrix for cryptographic changes, with the GxP risk, testing, and evidence each class requires. You also draft a cryptographic impact question for your change form. You organize the work into workstreams and repeatable change packages, such as one hybrid TLS configuration applied to one class of validated system. You set the gates and staffing, and agree what the steering committee does when a supplier or CDMO misses a committed date.

Module 8 Year-one plan, KPIs, and the asks

You assemble the day’s work into a year-one plan by quarter, with supplier questionnaires and the ownership register started in the first quarter. You set board KPIs for inventory coverage, signing anchors, supplier commitments, and agility. You list the decisions you need from executives, quality assurance, suppliers, CDMOs, and trading partners, and the instructor reviews each plan before the session ends.

Common questions

How technical is the day?

The day is about planning and program management. You need a working knowledge of your own systems and quality procedures, and no background in cryptography. The instructors explain the technical background to each decision in the module that needs it.

Do we need a cryptographic inventory before the day?

No. In Module 3, you plan the inventory from your GxP system list and the records you already hold. Teams that already have an inventory or a cryptographic bill of materials (CBOM) bring it and use it in Module 4.

Can one person attend alone?

Yes. You complete the same templates and note the questions that need a colleague. A mixed group from one company can answer more of those questions in the room.

Is the intensive vendor-neutral?

Yes. We favor no software vendor, equipment maker, CDMO, or cloud provider, and we judge algorithms and products against published standards and public evidence.

Where this course fits

We recommend Quantum-Safe Healthcare as preparation, though you can enroll without it. It covers pharma, health systems, and medical devices at overview depth. Participants who have taken it already know the terms we use during the day. Afterward, whoever will run the program can take PQC Migration Project Management, and whoever leads supplier and CDMO conversations can take PQC Vendor Governance and Supply Chain. Architects who design the qualified infrastructure can take Cryptographic Agility: Design and Implementation.

Why we teach this

This intensive is built on the Applied Quantum PQC Migration Framework, published openly under Creative Commons at pqcframework.org. The course author wrote the framework. No published extension of the framework covers pharma or GxP validation yet. The instructors teach the manufacturing and laboratory material from the framework’s OT & Critical Infrastructure Extension, and teach GxP validation from their own field work.

Certificate of Completion

Upon completion, you receive a Quantum Academy certificate of completion. It is separate from our professional certifications and states your CPE credits, one for each 60 minutes of teaching. CISSP, CISM, CRISC and PMP holders can claim them with their certifying body. The credits also count toward renewing a Quantum Academy certification. Our CPE credits page explains how to claim them.

Enrollment includes 180 days of access to the corresponding online on-demand course. Where that course is not yet published, the 180 days start on the day it is.

Book this course

Private Team Training

Bring this course to your organization: online or at your location, on your schedule, tailored to your environment.

Custom quote

Contact us about private training

Live Online

Join a scheduled instructor-led cohort over video, with real-time exercises, discussion, and direct Q&A.

US$1,499

7.5 CPE credits

  • Quantum-Safe Pharma Intensive – Live Online (EMEA & APAC), December 2026

    Live Online
    Virtual Event
    Live Online

    An eight-hour workshop for pharma and biotech teams. Work validation, record retention, and trading-partner constraints into a migration plan ready for quality review. IT quality and computerized system validation leads, manufacturing and laboratory systems owners, serialization and supply chain leads, regulatory operations, and CISOs and security architects who will own the plan. Send a mixed group from one company. The person who owns the validation master plan rarely owns the TLS configuration or the trading-partner credentials. Bring at least one person from quality assurance. Many of the sequencing decisions in this workshop are change control decisions. If you run a health system or build medical devices, the Quantum-Safe Healthcare Intensive is the working day for your estate.

    Get Tickets $1,499.00 20 tickets left
  • Quantum-Safe Pharma Intensive – Live Online (Americas), June 2027

    Live Online
    Virtual Event
    Live Online

    An eight-hour workshop for pharma and biotech teams. Work validation, record retention, and trading-partner constraints into a migration plan ready for quality review. IT quality and computerized system validation leads, manufacturing and laboratory systems owners, serialization and supply chain leads, regulatory operations, and CISOs and security architects who will own the plan. Send a mixed group from one company. The person who owns the validation master plan rarely owns the TLS configuration or the trading-partner credentials. Bring at least one person from quality assurance. Many of the sequencing decisions in this workshop are change control decisions. If you run a health system or build medical devices, the Quantum-Safe Healthcare Intensive is the working day for your estate.

    Get Tickets $1,499.00 20 tickets left

In-Person

Attend a scheduled classroom session: immersive, hands-on, and away from the distractions of a working day.

US$1,999

6.25 CPE credits

  • Quantum-Safe Pharma Intensive – In-Person, Zurich, April 2027

    Zurich – Venue to be announced Zurich, Switzerland
    In-Person

    A full-day workshop for pharma and biotech teams. Work validation, record retention, and trading-partner constraints into a migration plan ready for quality review. IT quality and computerized system validation leads, manufacturing and laboratory systems owners, serialization and supply chain leads, regulatory operations, and CISOs and security architects who will own the plan. Send a mixed group from one company. The person who owns the validation master plan rarely owns the TLS configuration or the trading-partner credentials. Bring at least one person from quality assurance. Many of the sequencing decisions in this workshop are change control decisions. If you run a health system or build medical devices, the Quantum-Safe Healthcare Intensive is the working day for your estate.

    Get Tickets $1,999.00 20 tickets left

Online on-demand courses are delivered through the Quantum Academy learning platform. Live online, in-person, and private team sessions are scheduled separately. Prices are shown in US dollars.

← All courses & certifications

Quantum Academy programs are educational and informational only. They are not legal, compliance, or engineering advice. A certificate of completion is not a professional certification, a government-issued license, an accredited degree, or academic credit, and completing a program does not guarantee employment, promotion, regulatory approval, or any other specific outcome.